Tag: triple hormone
Eli Lilly Reports Safety Data for Next-Generation Obesity Drug Retatrutide
Eli Lilly presented new safety data for retatrutide, its triple-hormone obesity drug, at the 2026 American Diabetes Association meeting. The…
Triple Hormone Obesity Drug Shows Promise in Early Safety Data at ADA 2026
Early safety data for triple hormone receptor obesity drugs presented at ADA 2026 show promise for monthly dosing regimens. These…
Submit Your Paper to GMJ
No APC until January 2027.